Pulmonary arterial hypertension (PAH), a rare, debilitating and fatal disease for which there is currently no available cure. There is compelling evidence for sphingolipid metabolites such as ceramides and sphingosine- 1-phosphate (S1P) in the pathobiology of pulmonary disorders. To facilitate the translation of current in vivo and in vitro observations on the role of SphK1/S1P/S1PR2 in PAH pathobiology this proposal will explore the hypothesis that the SphK1/S1P/S1PR2 signaling axis regulates physiologic, cellular and molecular pathways in PAH that result in pulmonary vascular remodeling. SA1 will define molecular mechanisms by which SphK1 regulates the hypertensive response in animal and smooth muscle cell culture models. SA2 will define the role of S1P signaling via S1PR2 in regulating pulmonary hypertension in animal and smooth muscle cell models. SA3 will conduct association studies to link SNPs within S1P biosynthetic/signaling pathway genes with susceptibility to PAH. SA4 will evaluate SK1 and S1PR2 antagonism as potential therapeutic strategies in PAH. The ultimate goal of this proposal is to lay the foundation for the development of novel therapeutic targets for PAH.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Fessel, Joshua P
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Indiana University-Purdue University at Indianapolis
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Singla, Sunit; Machado, Roberto F (2018) Death of the Endothelium in Sepsis: Understanding the Crime Scene. Am J Respir Cell Mol Biol 59:3-4
Saraf, Santosh L; Sysol, Justin R; Susma, Alexandru et al. (2018) Progressive glomerular and tubular damage in sickle cell trait and sickle cell anemia mouse models. Transl Res 197:1-11
Sysol, Justin R; Chen, Jiwang; Singla, Sunit et al. (2018) Micro-RNA-1 is decreased by hypoxia and contributes to the development of pulmonary vascular remodeling via regulation of sphingosine kinase 1. Am J Physiol Lung Cell Mol Physiol 314:L461-L472
DeLalio, Leon J; Keller, Alexander S; Chen, Jiwang et al. (2018) Interaction Between Pannexin 1 and Caveolin-1 in Smooth Muscle Can Regulate Blood Pressure. Arterioscler Thromb Vasc Biol 38:2065-2078
Dai, Zhiyu; Zhu, Maggie M; Peng, Yi et al. (2018) Therapeutic Targeting of Vascular Remodeling and Right Heart Failure in Pulmonary Arterial Hypertension with a HIF-2? Inhibitor. Am J Respir Crit Care Med 198:1423-1434
Brittain, Evan L; Thennapan, Thennapan; Maron, Bradley A et al. (2018) Update in Pulmonary Vascular Disease 2016 and 2017. Am J Respir Crit Care Med 198:13-23
Raslan, Rasha; Shah, Binal N; Zhang, Xu et al. (2018) Hemolysis and hemolysis-related complications in females vs. males with sickle cell disease. Am J Hematol 93:E376-E380
Duarte, Julio D; Kansal, Mayank; Desai, Ankit A et al. (2018) Endothelial nitric oxide synthase genotype is associated with pulmonary hypertension severity in left heart failure patients. Pulm Circ 8:2045894018773049
Singla, Sunit; Chen, Jiwang; Sethuraman, Shruthi et al. (2017) Loss of lung WWOX expression causes neutrophilic inflammation. Am J Physiol Lung Cell Mol Physiol 312:L903-L911
Patel, Monal; Predescu, Dan; Bardita, Cristina et al. (2017) Modulation of Intersectin-1s Lung Expression Induces Obliterative Remodeling and Severe Plexiform Arteriopathy in the Murine Pulmonary Vascular Bed. Am J Pathol 187:528-542

Showing the most recent 10 out of 23 publications